Clinical trial
A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex…
NCT00488722 · Tianjin Medical University, Other · Unknown status
Key facts
| NCT number | NCT00488722 |
|---|---|
| Title | A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer |
| Official title | A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer |
| Lead sponsor | Tianjin Medical University, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Zoladex |
| Start date | Apr 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Jun 20, 2007 |
| Last update posted | Jun 26, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: